Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
News for Sonendo, Inc. (SONX) centers on its activities as a commercial-stage medical technology and dental technology company. Sonendo develops and manufactures the GentleWave System, a platform for treating tooth decay and performing root canal therapy by cleaning and disinfecting microscopic spaces within teeth without removing tooth structure. Company news often reiterates this focus on saving teeth from tooth decay and improving clinical outcomes in endodontic care.
Investors and dental professionals following Sonendo’s news can expect regular updates on financial performance, including revenue from GentleWave consoles, procedure instruments and other products, as well as disclosures on gross margin, operating loss, adjusted EBITDA loss and free cash flow burn. The company has reported on a strategic reset and restructuring efforts aimed at stabilizing revenue, expanding margins and reducing operating expenses and cash burn.
Sonendo’s news flow also covers product and technology developments, such as the launch of ProControl for the GentleWave G4 System. This software update is described as enabling optimized cleaning of complex anatomy, increased procedure efficiency and the ability to adjust procedure fluid concentration levels when using the CleanFlow procedure instrument. Such announcements highlight the company’s focus on evolving its GentleWave platform and supporting personalized treatment in endodontics.
Additional news items may include capital-raising and financing transactions, such as private placements of common stock and amendments to credit facilities, as well as strategic transactions like the Asset Purchase Agreement to acquire Biolase assets through a bankruptcy court process and updates on related patent litigation. Leadership and organizational updates, including changes in operational roles, also appear in Sonendo’s press releases. For a consolidated view of these developments, this news page aggregates Sonendo’s public announcements and market-facing communications.
Sonendo (OTC Pink: SONX), a dental technology company specializing in the GentleWave® System, has promoted John McGaugh to Chief Operating Officer from his previous role as Senior Vice President of Operations.
Under the company's strategic reset initiated in early-2024, Sonendo has achieved revenue stabilization, improved gross margins, and reduced operating expenses and cash burn. In his expanded role, McGaugh will oversee quality, manufacturing, supply chain, technical services operations, and additionally lead the capital and consumables sales teams and commercial operations.
McGaugh, who joined Sonendo in May 2023, brings over 20 years of global manufacturing operations experience, including previous leadership positions at Abbott Vascular, Boston Scientific, and American Medical Systems.
Sonendo (NYSE:SONX), a dental technology company specializing in the GentleWave® System, reported Q2 2025 financial results. Revenue was $7.4 million, down 11% year-over-year due to lower console sales from a streamlined sales team. The company showed operational improvements with gross margin increasing to 41% (up 320 basis points) and reduced loss from operations to $3.9 million.
Notable improvements include a 47% reduction in Adjusted EBITDA loss to $3.0 million and a 61% decrease in free cash flow burn to $2.6 million. The company maintained a cash position of $9.3 million with $14.2 million outstanding under its credit facility. Management reaffirmed 2025 guidance, projecting revenue of $31-32 million and gross margins of 44-46%.
Sonendo Inc. (SONX) reported its Q4 and full-year 2024 financial results, showing mixed performance with significant cost improvements despite revenue decline. Q4 revenue was $8.3 million, down from $9.0 million in Q4 2023, while full-year revenue reached $31.7 million, compared to $34.6 million in 2023.
Notable improvements include substantial gross margin expansion, with Q4 GAAP gross margin increasing to 41.1% from 25.4% year-over-year. The company significantly reduced its operating loss to $5.6 million in Q4 and $29.4 million for the full year, representing improvements of 45.2% and 50.4% respectively. Free cash flow burn decreased by 69.4% to $2.9 million in Q4.
The company maintains approximately 650 active customers for its GentleWave System. As of December 31, 2024, Sonendo had $11.6 million in cash and investments, with $15.1 million outstanding under its term loan facility.
Sonendo (OTCQX: SONX) reported Q3 2024 financial results with total revenue of $8.0 million, a 2% decrease from Q3 2023. The company showed significant improvements in margins, with GAAP gross margin rising to 41.2% and adjusted gross margin reaching 42.6%. Operating loss reduced to $7.5 million, while free cash flow burn improved by 59% year-over-year to $4.3 million. GentleWave console revenue decreased 10% to $1.9 million, maintaining an active user base of over 800 customers. The company ended the quarter with $17.3 million in cash and cash equivalents.
Sonendo (OTCQX: SONX), a dental technology company known for the GentleWave® System, has announced the postponement of its third quarter 2024 earnings conference call, which was originally scheduled for November 12th, 2024. While the company will proceed with filing its audited financial results on the planned date, management has delayed the accompanying conference call indefinitely. Commentary on post-quarter events will be provided at a later date.
Sonendo (OTCQX: SONX), a dental technology company and developer of the GentleWave® System, has scheduled its third quarter 2024 financial results announcement for November 12, 2024, after market close. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors can join via phone using specific dial-in numbers or access the live webcast through the company's investor relations website.
Sonendo (OTCQX:SONX) has launched ProControl™, a new software update for their GentleWave® G4 System designed to enhance endodontic care. The update enables endodontists to adjust procedure fluid concentration levels when using the CleanFlow™ procedure instrument, allowing for personalized treatment and improved clinical outcomes. ProControl offers optimized cleaning of complex anatomy and increased procedure efficiency, representing a significant advancement in dental technology. The system's unique ability to automatically and precisely adjust fluid concentrations during treatment sets it apart from other endodontic systems.
Sonendo, Inc. (OTCQX: SONX), a dental technology company, has entered into an Asset Purchase Agreement to acquire substantially all assets of Biolase, Inc. and its subsidiaries for $14 million, plus assumption of certain liabilities and settlement of ongoing patent litigation. Biolase filed for Chapter 11 bankruptcy on October 1, 2024. Sonendo will be designated as the "stalking horse" bidder in a Bankruptcy Court-supervised process, subject to higher offers and court approval.
Sonendo's CEO, Bjarne Bergheim, expressed commitment to ensuring a smooth transition for Biolase customers, patients, suppliers, and vendors. The company anticipates cross-selling opportunities and cost reduction synergies as a combined entity. In January 2023, Sonendo's subsidiary, PIPStek , filed a patent infringement lawsuit against Biolase, claiming damages of not less than $59,000,000.